“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate

Por Shrivastava, Amresh, McGorry, P. D., Tsuang, Ming, Woods, Scott W., Cornblatt, Barbara A., Corcoran, Cheryl, Carpenter, William
Publicado em 2011

Erythrocyte glutathione levels as long-term predictor of transition to psychosis

Por Lavoie, S, Berger, M, Schlögelhofer, M, Schäfer, M R, Rice, S, Kim, S-W, Hesse, J, McGorry, P D, Smesny, S, Amminger, G P
Publicado no Transl Psychiatry (2017)

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

Por Amminger, G P, Mechelli, A, Rice, S, Kim, S-W, Klier, C M, McNamara, R K, Berk, M, McGorry, P D, Schäfer, M R
Publicado no Transl Psychiatry (2015)

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis

Por Ansell, B. R. E., Dwyer, D. B., Wood, S. J., Bora, E., Brewer, W. J., Proffitt, T. M., Velakoulis, D., McGorry, P. D., Pantelis, C.
Publicado no Psychol Med (2015)

Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study

Por Edwards, J., Cocks, J., Burnett, P., Maud, D., Wong, L., Yuen, H. P., Harrigan, S. M., Herrman-Doig, T., Murphy, B., Wade, D., McGorry, P. D.
Publicado em 2011

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

Por Berger, M E, Smesny, S, Kim, S-W, Davey, C G, Rice, S, Sarnyai, Z, Schlögelhofer, M, Schäfer, M R, Berk, M, McGorry, P D, Amminger, G P
Publicado no Transl Psychiatry (2017)

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers

Por Clark, S R, Baune, B T, Schubert, K O, Lavoie, S, Smesny, S, Rice, S M, Schäfer, M R, Benninger, F, Feucht, M, Klier, C M, McGorry, P D, Amminger, G P
Publicado no Transl Psychiatry (2016)

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

Por Bousman, C A, Yung, A R, Pantelis, C, Ellis, J A, Chavez, R A, Nelson, B, Lin, A, Wood, S J, Amminger, G P, Velakoulis, D, McGorry, P D, Everall, I P, Foley, D L
Publicado em 2013

Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis

Por Tognin, S., Riecher-Rössler, A., Meisenzahl, E. M., Wood, S. J., Hutton, C., Borgwardt, S. J., Koutsouleris, N., Yung, A. R., Allen, P., Phillips, L. J., McGorry, P. D., Valli, I., Velakoulis, D., Nelson, B., Woolley, J., Pantelis, C., McGuire, P., Mechelli, A.
Publicado em 2014

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

Por Di Biase, M A, Zalesky, A, O'keefe, G, Laskaris, L, Baune, B T, Weickert, C S, Olver, J, McGorry, P D, Amminger, G P, Nelson, B, Scott, A M, Hickie, I, Banati, R, Turkheimer, F, Yaqub, M, Everall, I P, Pantelis, C, Cropley, V
Publicado no Transl Psychiatry (2017)

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical cour...

Por Nelson, B., Amminger, G. P., Yuen, H. P., Markulev, C., Lavoie, S., Schäfer, M. R., Hartmann, J. A., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G., Chen, E. Y. H., de Haan, L., Nieman, D. H., Nordentoft, M., Riecher-Rössler, A., Verma, S., Thompson, A., Yung, A. R., McGorry, P. D.
Publicado no NPJ Schizophr (2018)